Cmc Biologics

CMC Biologics to manufacture mAbs for Malaria Vaccine Initiative

CMC Biologics to manufacture mAbs for Malaria Vaccine Initiative

By Zachary Brennan

The Bill & Melinda Gates Foundation’s PATH Malaria Vaccine Initiative (MVI) has selected CMC Biologics for process development and manufacture of specific monoclonal antibodies (mAbs) to test for their capacity to protect humans from malaria infection.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers